psychotherapy | CARLAT PUBLISHING

Ketamine Comes Home

February 26, 2023

Kellie Newsome, PMHNP and Chris Aiken, MD

Online clinics delivered at-home ketamine throughout the pandemic, and we’re just becoming aware of the consequences.

EXPERT Q&A

The Enduring Value of Talking Therapy

October 30, 2022

Allen Frances, MD

Allen Frances, MD. Dr. Frances has no financial relationships with companies related to this material.

An interview with Dr. Allen Frances about the enduring value of talk therapy, and insights into how therapy is being used in modern clinical practice.

School Inclusion: What You Need to Know

October 3, 2022

Joshua Feder and Mara Goverman

When a school placement is a bad fit, medication and therapy are unlikely to make much difference. In this episode, we will help you understand and assist your patients to optimize their success in the least restrictive placement.

How to Identify and Treat Apathy and Late-Life Depression

October 1, 2022

Rehan Aziz, MD and Julia Cromwell, MD

Rehan Aziz, MD. associate program director, geriatric psychiatry fellowship program, Jersey Shore University Medical Center; associate professor of psychiatry and neurology, Hackensack Meridian School of Medicine, Nutley, NJ. Julia Cromwell, MD. Inpatient geriatric psychiatrist, Mass General Brigham Salem Hospital, Salem, MA.

Dr. Aziz and Dr. Cromwell, authors of this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

We provide tips on distinguishing between apathy and depression, as well as recommendations on how to manage these disorders.

Understanding the Varieties of Depression

September 25, 2022

Ronald Pies, M.D.

Ronald W. Pies, MD

Professor Emeritus of Psychiatry and Lecturer on Bioethics and Humanities, SUNY Upstate Medical University; Clinical Professor of Psychiatry, Tufts University School of Medicine; Editor-in-Chief Emeritus, Psychiatric Times.

Dr. Pies, expert for this educational activity, has disclosed no relevant financial relationship(s) with ineligible companies to disclose.

Depression is not one illness, but how divide it up? Ronald Pies highlights subtypes of
depression worth paying attention to in practice.

SAINT TMS Cleared for Treatment-Resistant Depression

September 12, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

On 9/6/22 the FDA approved Stanford’s SAINT Neuromodulation, an accelerated version of TMS that has raised hopes with unusually high remission rates.

Diagnosing and Treating Avoidant/Restrictive Food Intake Disorder

August 8, 2022

Joshua Feder, MD, Mara Goverman, and Jennifer Thomas, PhD

Nine years after DSM-5, Avoidant Restrictive Food Intake Disorder (ARFID) is still settling into clinical practice. Dr. Jennifer Thomas helps sort out the differential diagnosis between ARFID, anorexia, and other conditions and plan treatment in the context of comorbid conditions, such as anxiety disorders and Autism Spectrum Disorder.

Addiction and Borderline Personality Disorder

July 1, 2022

Ashley Pierson, PhD

Ashley Pierson, PhD

Assistant Professor of Psychiatry and acting director of DBT services, General Adult Intensive Outpatient Program, Yale University, New Haven, CT.

Dr. Pierson, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Borderline personality disorder is highly comorbid with substance use disorders for reasons that are described by Dr. Pierson. She also reviews some basics of dialectical behavioral therapy, the gold standard treatment for borderline personality disorder, and shows us how therapeutic principles can be applied the treatment of addiction.

Addiction and Borderline Personality Disorder

July 1, 2022

Ashley Pierson, PhD

Assistant Professor of Psychiatry and acting director of DBT services, General Adult Intensive Outpatient Program, Yale University, New Haven, CT.

Dr. Pierson, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Borderline personality disorder is highly comorbid with substance use disorders for reasons that are described by Dr. Pierson. She also reviews some basics of dialectical behavioral therapy, the gold standard treatment for borderline personality disorder, and shows us how therapeutic principles can be applied the treatment of addiction.